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Abstract CFTR-NBF-2 was expressed in Escherichiu cofi in 
fusion with glutathione-4transferase, the soluble portion was 
purified and identified as a stuctured protein by its CD spectrum. 
Association reactions of the recombinant NBF-2 with adenine 
nucleotides were monitored qualitatively by demonstrating its 
ability to bind specifically to ATP-, ADP- and AMP-affinity 
agarose and quantitatively by recording the fluorescence en- 
hancement of excited trinitrophenol (TNP)-labelled adenine nu- 
cleotides occuring as a result of binding to NBF-2. Best-fit mono- 
phasic binding curves to the fluorescence data indicated Kd values 
of 22 PM for TNP-ATP, 39 PM for TNP- ADP and 2.1 PM 
for TNP-AMP. The corrected Kd values for unlabelled adenine 
nucleotides competing with the fluorophores were determined to 
be 37 PM for ATP, 92 PM for ADP and 12 PM for AMP. The 
recombinant NBF-2 did not show any hydrolytic activity on ATP 
(detection limit 0.001 s-l). Our findings support the concept of 
a central role of NBF-2 in CFTR activity regulation acting as an 
allosteric switch between channel opening and closing and give the 
first experimental evidence that the channel inhibitor AMP could 
act via NBF-2. 
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1. Introduction 
Cystic fibrosis is the most common fatal autosomal recessive 
genetic disease affecting Caucasian populations [ 11. The disease 
results from mutations in the gene that codes for the cystic 
fibrosis transmembrane conductance regulator (CFTR) chlo- 
ride channel, which has been predicted to be composed of two 
motifs of six transmembrane spanning segments followed by a 
nucleotide binding fold that are separated by a unique regula- 
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5’-monophosphate; AK, adenylate kinase. 
tory (R) domain [2]. Both CFTR nucleotide binding folds, 
NBF-1 and NBF-2, were identified by the occurrence of Walker 
A and B consensus sequences [3] characterizing NBFs in the 
ATP-binding cassette family [4]. CFTR channel activation re- 
quires both phosphorylation by CAMP-dependent protein ki- 
nases [5] and the presence of cytosolic hydrolyzable MgATP in 
millimolar concentrations [6,7]. Cytosolic ADP [8] as well as 
AMP [7] have been shown to act as inhibitors of channel activ- 
ity. Electrophysiological data suggest that for channel activa- 
tion by ATP both NBF-1 and NBF-2 are required [9], while 
channel inhibition by ADP seems to be a function of NBF-2 
[8]. The latter domain is coded by exons 19-23 of the CFTR 
gene and defined as the CFTR sequence from Y1219 to R1386 
[2]. It has recently been reported that a 51-amino acid synthetic 
peptide segment from NBF-2 (El228 to T1278) is able to bind 
TNP-ATP and that comparatively high concentrations of ATP 
can displace TNP-ATP with a Kd of 0.46 mM. The capacity to 
bind TNP-ADP and TNP-AMP has been noted to be much less 
[IO]. Furthermore there is evidence that the NBF-2 mutation 
G1349D corresponding to the CF-associated replacement of 
glycine 551 with aspartic acid in NBF-1 disrupts TNP-ATP and 
[y-“PI2-azido-ATP binding of a recombinant NBF-2 protein 
recovered from inclusion bodies [l 11. Up to now no experimen- 
tal data have been published describing the interactions of all 
three unlabelled adenine nucleotides with NBF-2. 
In the present study we describe the expression, purification 
and characterization of a soluble recombinant protein compris- 
ing the entire predicted second nucleotide binding fold of 
CFTR fused to glutathione-S-transferase which shows non- 
hydrolytic interactions of high affinity with all three adenine 
nucleotides. First experimental evidence that the channel inhib- 
itor AMP could act via NBF-2 is presented. 
2. Experimental 
2.1. Construction of the expression vector pGEX-NBF-2 
RNA of the CFTR expressing [12] human colonic adenocarcinoma 
cell line CaCo-2 (American Type Cell Culture Company; Rockville, 
MD) was isolated by single step acid guanidinium thiocyanatelphenoll 
chloroform extraction [13]. NBF-2 coding sequence was gained from 
reverse transcribed CFTR-mRNA by PCR (performed in 10 mM Tris- 
HCl, pH 8.0, 50 mM KCl, 1.5 mM MgCl,, 0.1 mg/ml gelatine, 200 PM 
of each dNTP, 1.4 PM of each primer and 0.02 U/p1 Taq-polymerase 
from Amersham; cycle conditions: 1 min 94°C I min 6O”C, 1 min 40 
s 72°C; 2 x 30 cycles). For pre-amplification the oligonucleotides 
S-CACGTGAAGAAAGATGACATC-3’ and 5’-CGAGCTCCAAT- 
TCCATGAGC-3’ were used. The booster PCR was carried out 
with 5’- GGCCAAATGACTGTCAAAGATC-3’ and S-CAGAGA- 
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ATTACTGTGCAATCAG-3’ as primers defining and amplifying the 
CFTR coding sequence from base 3,754 to base 4,331 [2]. The final 
amplification product was introduced into the SmaI site of the expres- 
sion vector pGEX-3X [14] (obtained from Pharmacia) according to 
standard procedures [ 151 using competent recA- E. coli HB 10 1. By this 
strategy the C-terminal coding region of the glutathione-S-transferase 
gene of the vector was fused in frame to the inserted NBF-2 coding 
DNA. Plasmids of transformands showing positive inducible expres- 
sion of a fusion protein of the appropriate size were isolated and both 
strands of the inserted DNA including vector-insert junctions were 
totally sequenced using an Applied Biosystems automated sequencer to 
verify accordance with the published sequence [2] and to exclude amino 
acid substitutions in the CFTR-NBF-2 part of the expressed fusion 
protein due to fidelity constraints of the PCR reaction. 
2.2. Overexpression and purification of GST-NBF-2 fusion proteins 
E. coli HBlOl harboring the expression vector pGEX-NBF-2 was 
grown at 32°C in dyt-medium (5 g NaCl, 10 g bacto yeast extract, 16 g 
bacto tryptone per liter, pH 7.0; 200 pg ampicillin/ml). They were 
induced with 0.1 mM IPTG at AzSO of approx. 1.3 for 3.5 hat 25-28°C. 
Cells were harvested by centrifugation at 4000 x g for 20 min and 
washed once with ice-cold PBS [15]. They were resuspended in 10 ml 
ice-cold PBS/O. 1 mM PMSF per gram wet weight and lysed by passing 
the suspension twice through a French Press at 3500 psi. Triton X-100 
was added to a final concentration of 1% and after gentle mixing for 
35 min at room temperature the lysate was centrifuged at 10,000 x g for 
15 min at 4°C. For reasons discussed below the supernatant of soluble 
proteins was incubated with 5 mM MgATP for 30 min at 37°C. Imme- 
diately afterwards, 1 ml 50% glutathione-Sepharose 4B (Pharmacia, 
binding capacity 5 mg of fusion protein/ml of bed volume) per 40 ml 
supernatant was added, followed by an one-hour incubation on ice with 
occasional gentle mixing. After decanting the supernatant, the beads 
were washed once with 100 volumes PBS/l% Triton X-100 and five 
times with 100 volumes PBS without Triton X-100 before they were 
filled into a suitable column. The GST-NBF-2 fusion protein was eluted 
with 10 mM reduced glutathione dissolved in 50 mM Tris-HCl, pH 8.0 
(final pH 7.5), at a flow rate of 0.5 ml/min. Fractions containing fusion 
proteins detected by their absorbance at 280 nm were pooled and 
applied in 500 ~1 portions to a Superose 12 preparative FPLC column 
(Pharmacia) pre-equilibrated with 50 mM Tris-PO,, pH 7.5. Fractions 
eluted from the Superose 12 column were monitored by their absorb- 
ance at 280 nm and subsequently by SDS-PAGE. Fractions of different 
runs corresponding to the same reproducible, well-resolved peak of a 
48 kDa protein (determined by comparision with runs of marker pro- 
teins) were pooled. The amount of fusion protein was quantified by 
determination of the absorbance at 280 nm using a molar absorption 
coefficient of 73.390 M-’ .crn-‘. 
2.3. Amino acid sequence analysis 
For N-terminal sequencing 100-200 pmol of the purified fusion pro- 
tein were used directly. For sequencing internal portions of the fusion 
protein 100 pmol of the purified protein were incubated with 1 pg 
endoproteinase Lys-C (Boehringer Mannheim, sequencing grade) for 
14 h at 37°C. Digestion products were isolated by HPLC as follows: 
samples were loaded onto a Supersphere 60 RP-SELECT B column 
(125 mm x 2 mm; Merck) and eluted using a linear gradient of O-60% 
(by vol.) acetonitrile in 0.1% (by vol.) trifluoroacetic acid, within 60 
min, at a flow rate of 0.3 ml/min. Automated amino acid sequencing 
was performed using a gas-phase sequencer 473A (Applied Biosys- 
terns). 
2.4. Circular dichroism spectroscopy (CD) 
CD snectra (190-250 nm) of 0.8 uM GST-NBF-2 in 50 mM Tris-PO,. 
pH 7.5: were obtained at iO°C using an Auto-Dichrograph Mark I+ 
(Jobin Yvon Division d’Instruments S.A.) spectropolarimeter and a 0.1 
cm pathlength demountable cell. Analysis of the smoothed average of 
ten separate spectra for secondary structure was done with the CON- 
TIN FIT program [16]. 
2.5. Qualitative adenine nucleotide binding studies 
1 nmol of glutathione-S-transferase or GST-NBF-2 was incubated 
with 50 ~1 ATP-, ADP- or AMP-agarose (Sigma) in 500 ~1 50 mM 
Tris-HC1, pH 7.5/0.1% Triton X-100 for 50 min on ice. Beads were 
washed twice with 1 ml of the incubation buffer before they were 
resuspended in 50 ~1 SDS sample buffer [17] and boiled for 10 min. The 
supernatant was subjected to SDS-PAGE followed by staining with 
Coomassie blue. Specific nucleotide binding was demonstrated by car- 
rying out the described binding assay in the presence of 20 mM ATP, 
ADP or AMP (from Boehringer Mannheim, stock solutions dissolved 
in 50 mM Tris, pH adjusted to pH 7.5). 
2.6. Determination of nucleotide binding characteristics 
The fluorescence enhancement of varying concentrations of TNP- 
labelled adenine nucleotides (Molecular Probes Inc., Eugene, OR) in 
the presence of 1.8 PM GST-NBF-2 or an equivalent amount of gluta- 
thione-S-transferase as control in 50 mM Tris-HCI, pH 7.5, was re- 
corded at 25°C using a SPEX FluoroMax fluorometer (integration time 
8 s). All titrations were carried out with vertically polarized excitation 
II = 408 nm (slit width 2.35 mm) and horizontally polarized emission 
A = 545 nm (slit width 3.5 mm). Fluorescence data were corrected for 
inner filter effect using the equation 
E(c) = E,(c). emflc (I) 
where c is the concentration of the fluorophore, p is an attenuation 
coefficient dependent on terms of application, E(cj is the emitted light 
and E,(c) is the emitted light without filter effect that should be propor- 
tional to c in a constant solvent [18]: 
E,(c) = k’ c (2) 
(k’ is a constant). Concentration dependent correction factors d’ were 
calculated after determination of fi for an individual experiment using 
the algebraic transformation of Eq. 1 with E,,(c) substituted by 
Eq. 2 
In [E(c)/c] = -PC + k (3) 
(k is a constant) that presents fi as slope of a regression line fitted to 
the transformed data. 
To the data corrected for volume dilution and filter effect monopha- 
sic binding curves were fitted using equations of a non-classical binding 
model allowing for depletion of free ligand by complex formation, as 
published by Mullen et al. [19]. In the unlabelled nucleotide titrations 
the data were fitted by assuming binding competition between the 
nucleotide and its TNP-analogue at a single site. Thereby the concentra- 
tion of the protein-bound unlabelled nucleotides was considered to be 
negligible in comparison with its total concentration. 
2.7. Coupled assay for ATPase activity 
A coupled ATP-regenerating enzyme system was employed following 
a method described by Nsrby [20]. In a total volume of 1 ml, 1.8 PM 
(87.46 pglml) GST-NBF-2 was incubated together with 3 mM ATP, 
0.12 mM NADH, 3 mM phosphoenolpyruvate, 10 pug lactate dehydro- 
genase and 30 pg pyruvate kinase (Boehringer Mannheim) in 50 mM 
Tris-HCI, pH 7.0/4 mM MgClz at 30°C and AA,,,jdt was monitored. 
Addition of 3 mM ADP at the end of the reaction should verify that 
the assay would have indicated nascent ADP. In order to detect nascent 
AMP, 10 pug (3.6 U) adenylate kinase, catalyzing the reaction 
ATP + AMP * 2 ADP, was added to the assay. Addition of 0.04 mM 
AMP at the end of the incubation period demonstrated that the assay 
would have indicated nascent AMP. 
3. Results and discussion 
3.1. Overexpression, purcjication and characterization of soluble 
GST-NBF-2 
The expression vector pGEX-NBF-2 was constructed as de- 
scribed in section 2 to express the CFTR sequence from G1208 
to L1399 (numbering according to [2]). We used a cytoplasmic 
expression system, since the C-terminal nucleotide binding fold 
seems to be intracellular [21]. As shown in Fig. 1, the expression 
of a 48 kDa (26 kDa for GST + 22 kDa for NBF-2) fusion 
protein under the control of the tat promotor after induction 
with IPTG is strikingly evident. Most of the overexpressed 
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Fig. 1. Expression and purification of recombinant GST-NBF-2. (a) Lane 1, lysate of uninduced E. coli (3 x lo8 cells) bearing the expression vector 
pGEX-NBF-2; lane 2, lysate of E. coli carrying pGEX-NBF-2 induced for 3.5 h with 0.1 mM IPTG (3 x lo8 cells); lane 3, insoluble proteins of the 
inducted E. coli employed in lane 2 (not used in further purification); lane 4, soluble proteins of the inducted E. coii of lane 2, which were subsequently 
further purified by affinity chromatography; lane 5, 6, eluates from glutathione-Sepharose: in difference to lane 5, E. cob protein extract pretreated 
with 5 mM MgATP (30 min, 37°C) was employed in lane 6 (Coomassie stained 12.5% SDS-PAA-gel). (b) 6pg of the final gel filtration purified fraction 
was run on a silver stained 12.5% SDS-PAA-gel. 
protein was found to be insoluble. In order to increase the 
soluble fraction of the NBF-2 fusion protein we lowered induc- 
tion temperatures to 25-28°C and inductor concentrations to 
0.1 mM thus allowing a higher proportion of protein to achieve 
a folded state [22]. As GST exhibits high affinity for glutathi- 
one, binding of GST-NBF-2 to glutathione-Sepharose pro- 
vided an effective purification step. Interestingly, a second pro- 
tein of 60 kDa was eluted from the glutathione-Sepharose 
affinity column by an excess of free reduced glutathione in 
addition to the 48 kDa fusion protein (Fig. 1) and was not 
found in a control experiment expressing GST without fusion 
partner. A tryptic digestion fragment of this protein revealed 
the amino acid sequence L-Q-E-R-V-A-K, which was found to 
be specific for the E. coli heat shock protein groEL [23] where 
it is preceded by lysine thus identifying the peptide as a tryptic 
digestion fragment. GroEL is a bacterial folding complex of 
distinct quaternary structure with 14 subunits of 60 kDa ar- 
ranged in two stacked heptameric rings [24] which is able to 
bind one or two protein molecules per 14-mer in the conforma- 
tion of a ‘molten globule’ [25]. Folding and release of the bound 
protein requires ATP hydrolysis [25]. Because of the mentioned 
stoichiometry, less than 15% of the soluble recombinant NBF-2 
seemed to be bound by groEL, estimated by the amount of each 
protein visible on a SDS gel after Coomassie blue or silver stain. 
As expected, groEL was missing in elution fractions when the 
extracts of soluble E. coli proteins were pretreated with 
MgATP. Therefore this step was included in the purification 
protocol. A very small amount of contaminating proteins of M, 
25 to 30 kDa were present in the elution fraction of the gluta- 
thione affinity column. GST-NBF-2 was separated from these 
contaminants by gel filtration on Superose 12. The effectiveness 
of the major purification steps is illustrated in Fig. la,b. To 
demonstrate the purity of the NBF-2 fusion protein, a 12.5% 
gel was heavily loaded and stained with silver (Fig. lb). No 
other proteins larger than the cutoff molecular weight of the gel 
were detectable. N-terminal sequence analysis revealed only 
one N-terminal sequence in agreement with the 5 N-terminal 
residues of the GST fusion partner. In addition, we sequenced 
an internal protein fragment of 11 residues (L-I-E-G-R-G-I-P- 
G-Q-M) that was identified as the predicted connecting link 
between GST and NBF-2. 
Deconvolution of circular dichroism spectra using the CON- 
TIN FIT program [16] indicated a structured protein with sec- 
ondary structural elements being distributed as approximately 
21% helix, 28% P-sheet and 51% elements belonging to the 
‘remainder’ class (including turns and random coil). The overall 
yield of natively folded GST-NBF-2 fusion protein was approx- 
imately 100 pg (2 nmol) per liter of E. coli culture. 
3.2. SpeciJic binding of CFTR-NBF-2 to adenine nucleotide 
afjnity agarose 
Fig. 2 shows binding of GST-NBF-2 to ATP-, ADP- and 
AMP-agarose. GST failed to be retained by either agarose. In 
the presence of an excess of unbound nucleotides binding of the 
NBF-2 fusion protein was markedly reduced. This emphasizes 
that the observed binding to the affinity agarose is due to a 
specific interaction of NBF-2 with the agarose-attached ade- 
nine nucleotides. However, these results do not allow to make 
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Fig. 2. Binding of the recombinant NBF-2 fusion protein to ATP-, 
ADP- and AMP-affinity agarose. Lanes 1,4, 7: binding of glutathione- 
S-transferase (GST) to ATP- (lane 1), ADP- (lane 4) and AMP- (lane 
7) agarose. Lanes 2, 5, 8: binding of the NBF-2 fusion protein to ATP- 
(lane 2), ADP- (lane 5) and AMP- (lane 8) agarose. Lanes 3, 6 and 9: 
binding of the NBF-2 fusion protein to ATP- (lane 3), ADP- (lane 6) 
and AMP- (lane 9) agarose in the presence of an excess (20 mM) of the 
corresponding nucleotide (Coomassie stained 12.5% SDS-PAA-gel). 
quantitative statements concerning nucleotide binding of NBF- 
2, since the three applied affinity matrices exhibit different 
unspecific protein binding properties. 
3.3. Quantifying nucleotide binding of NBF-2 
Nucleotide binding characteristics were obtained by measur- 
ing the fluorescence enhancement of adenine nucleotides la- 
belled with the extrinsic fluorophore trinitrophenol (TNP). 
Concentration-dependent enhancement as a consequence of 
increased quantum yield occurs if the fluorophore is transferred 
into a less polar environment like a protein’s nucleotide binding 
pocket [18]. A specific signal due to nucleotide binding is ex- 
pected to be readily de-enhancable by an excess of the corre- 
sponding unlabelled nucleotide. Since NBF-2 contains hydro- 
phobic amino acid sequences, aggregate formation during fluo- 
rescence measurements may cause light scattering as a result of 
increasing turbidity. Therefore vertically polarized excitation 
(408 nm) and horizontally polarized emission (545 nm) were 
used to minimize scattered light, an effect that could be con- 
trolled by looking at the Raman scatter [26]. In addition, pro- 
tein concentrations were kept low (1.8 PM). 
As illustrated in Fig. 3, all three TNP-labelled adenine nucle- 
otides bound to the NBF-2 fusion protein and were effectively 
displaced by the corresponding unlabelled nucleotide. In the 
presence of 6 M urea the capacity to bind adenine nucleotides 
was completely lost. No specific enhancement was observed 
using GST instead of the GST-NBF-2 fusion construct (data 
not shown). All three adenine nucleotides were bound with high 
affinity displaying Kd values of 22 ,uM for TNP-ATP, 39 ,uM 
for TNP-ADP and 2.1 ,uM for TNP-AMP. The corrected Kd 
values for unlabelled adenine nucleotides were determined to 
be 37 PM for ATP, 92 PM for ADP and 12 ,uM for AMP. The 
calculated Kd values for TNP labelled nucleotides are in good 
agreement with those obtained for the corresponding unla- 
belled nucleotides. This strongly suggests that indeed a nucleo- 
tide interaction has been observed with negligible influence of 
the TNP group on protein ligand association. Recently pub- 
lished work investigating nucleotide binding of a 51-amino acid 
synthetic peptide corresponding to the CFTR sequence from 
El228 to T1278 (numbering according to [2]), containing the 
Walker A motif of NBF-2, indicated much lower capacity of 
ATP to replace TNP-ATP, low ability to bind TNP-ADP and 
very low ability to bind TNP-AMP [lo]. In our opinion, this 
discrepancy emphasizes that the whole predicted NBF-2 se- 
quence is necessary to provide the structural and functional 
integrity of that domain. 
The observed affinity for nucleotides was even better than 
expected from electrophysiological data [6-81. A hypothetical 
explanation would be that the NBF-2 nucleotide binding 
pocket of native, membrane inserted CFTR is not as well acces- 
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Fig. 3. Adenine nucleotide binding characteristics of the NBF-2 fusion 
protein. The fluorescence enhancement (4fi of TNP-labelled adenine 
nucleotides due to binding to NBF-2 is illustrated in the absence (solid 
symbols) or in the presence of 6 M urea (open symbols). Data were 
normalized referring to the asymptotic maximum of the best-fit curve 
(AF,,,). Comparable binding curves were obtained in three separate sets 
of experiments. Kd values were calculated from the depicted sets of data 
giving the best fit to the theoretical binding equation [19], as indicated 
by the lowest standard deviations (1.48 ,uM, 6.95 PM, 0.32 .uM for Kd 
of TNP-ATP, TNP-ADP, TNP-AMP, and 4.39 ,uM, 4.65 PM, 1.93 ,uM 
for Kd of ATP, ADP, AMP, respectively). 
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Fig. 4. Absence of ATP-hydrolysing activity of the NBF-2 fusion pro- 
tein in a coupled enzymatic assay. ‘AK indicates addition of adenylate 
kinase to detect nascent AMP. Control: performance of the assay with- 
out GST-NBF-2. At the end of an experiment, the adenine nucleotide 
of interest (ADP or AMP) was added in order to verify that the assay 
was still functional. 
sible as that of the isolated and solubilized domain. It is tempt- 
ing to speculate that NBF-2 might be at least partially immersed 
into the membrane, as it is reasonable to assume in the case of 
NBF-1 [27]. 
3.4. Investigation of possible enzymatic activity of recombinant 
NBF-2 regarding ATP hydrolysis 
A coupled ATP-regenerating enzyme system was employed 
that is able to detect nascent ADP by a decrease in the concen- 
tration of NADH present in the assay, monitored by photo- 
metric analysis [20]. ATP was added last in a concentration of 
3 mM, estimated to be sufficient to saturate NBF-2 with regard 
to its Kd. The small diminution of A,,, observed immediately 
after adding ATP is due to the presence of a small amount of 
ADP in the ATP preparation (Fig. 4). Interestingly, the change 
is significantlly slower when NBF-2 is present than in the con- 
trol lacking NBF-2. This difference may be explained by bind- 
ing of ADP to NBF-2 delaying its entry into the coupled enzy- 
matic assay reactions. Over a time period of 20 min no signifi- 
cant ATPase activity was observed above the detection limit of 
0.11 mU (turnover 0.001 s-‘) which is imposed by baseline 
activity of the control due to some small ATPase contamination 
of the employed assay enzymes. Using the same assay, ATPase 
activity of (Na’,K’)ATPase (from dog kidney, specific activity 
1.3 Ulmg, Sigma) could readily be detected with an enzyme 
concentration of 0.1 pg/ml as lower detection limit (data not 
shown). Finally, adenylate kinase was added in order to detect 
AMP that would result if NBF-2 should catalyze hydrolytic 
liberation of pyrophosphate from ATP. Over a period of 30 min 
no significant decline in A,,, was observed (see Fig. 4). The very 
small but slightly delayed diminution of A,,, immediately after 
adding adenylate kinase indicates traces of AMP present in the 
enzyme preparation, the delay pointing out an initial competi- 
tion in AMP binding between NBF-2 and adenylate kinase. 
These findings do, however, not totally exclude the possibil- 
ity that there is a weak hydrolytic activity of less than 0.1 mU 
or that enzymatic activity might be uncovered with different 
ionic buffer compositions. Nevertheless, regulation mecha- 
nisms of CFTR activity based on non-hydrolytic nucleotide 
binding [7] to NBF-2 appear to be more likely. 
3.5. Conclusions 
Our data show that the second predicted nucleotide binding 
fold of CFTR can gain a structure providing ability to bind 
ATP and ADP with high and comparable affinities. They are 
consistent on a single domain level with electrophysiological 
data obtained with CFTR wild type and mutants [8,9] suggest- 
ing that NBF-2 plays a crucial role in CFTR channel regula- 
tion, regarding ATP-mediated activation of chloride currents 
as well as ADP-mediated channel inhibition. Moreover, our 
results provide the first direct experimental evidence that the 
observed strong inhibitory effect of AMP on chloride conduct- 
ance [7] could be a function of NBF-2. 
Acknowledgements: The authors are grateful to L. Moroder, Max- 
Planck-Institut fur Biochemie, Martinsried, for using his CD spectro- 
polarimeter as well as to H. Domdey and B. Obermeier-Skrobranek, 
Laboratorium fur molekulare Biologie, Martinsried, for DNA sequenc- 
ing. They wish to thank E. Weyher-Stingl, C. Huber and R.J. Soares 
Torquato for technical assistance and R. Mentele for N-terminal amino 
acid sequencing, performed as a guest in the laboratory of F. 
Lottspeich. C.R. is in particular grateful to H. Fritz, Abteilung fur 
Klinische Chemie und Klinische Biochemie der Chirurgischen Klinik 
Innenstadt, Miinchen, for generously supporting this work and provid- 
ing laboratory space. This work was supported by the Sonder- 
forschungsbereich 207 of the Ludwig-Maximilians-University of Mu- 
nich and from the Dr. von Haunersches Kinderspital. 
References 
111 
121 
[31 
[41 
[51 
161 
ti; 
191 
1101 
Ull 
v-21 
v31 
[I41 
[I51 
L1f-I 
Boat, T.F., Welsh, M.J., Beaudet, A.L. (1989) in: The Metabolic 
Basis of Inherited Disease (Striver, C.L., Beaudet, A.L., Sly, W.S. 
and Valle, D. Eds.) pp. 264992680, 6th edn., McGraw-Hill, New 
York. 
Riordan, J.R., Rommens, J.M., Kerem, B.-S., Alon, N., 
Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., 
Chou, J.-L., Drumm, M.L., Iannuzzi, M.C., Collins, F.S. and 
Tsui, L.-C. (1989) Science 245, 10661073. 
Walker, J.E., Saraste, M., Runswick, M.J. and Gay, N.J. (1982) 
EMBO J. 1, 945951. 
Hyde, SC., Emsley, P., Hartshorn, M.J., Mimmack, M.M., 
Gileadi. U.. Pearce. S.R.. Gallagher. M.P.. Gill. D.R.. Hubbard. 
R.E. and Higgins, C.F. (1990) Nature 346; 3621365. ’ 
Cheng, S.H., Rich, D.P., Marshall, J., Gregory, R.J., Welsh, M.J. 
and Smith, A.E. (1991) Cell 66, 1027-1036. 
Anderson, M.P., Berger, H.A., Rich, D.P., Gregory, R.J., Smith, 
A.E. and Welsh, M.J. (1991) Cell 67, 7755784. 
Quinton, P.M. and Reddy, M.M. (1992) Nature 360, 79-81. 
Anderson, M.P. and Welsh, M.J. (1992) Science 257, 1701- 
1704 
Smit, L.S., Wilkinson, D.J., Mansoura, M.K., Collins, F.S. and 
Dawson, D.C. (1993) Proc. Natl. Acad. Sci. USA 90, 9963-9967. 
Ko, Y.H., Thomas, P.J. and Pedersen, P.L. (1994) J. Biol. Chem. 
269, 1458414588. 
Logan, J., Hiestand, D., Daram, P., Huang, Z., Muccio, D.D., 
Hartman, J., Haley, B., Cook, W.J. and Sorscher, E.J. (1994) 
J. Clin. Invest. 94, 228-236. 
Bear, C.E. and Reyes, E.F. (1992) Am. J. Physiol. 262, C25 l- 
C256. 
Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162, 156 
159 
Smith, D.B. and Johnson, K.S. (1988) Gene 67, 3140. 
Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular 
Cloning: A Laboratory Manual, 2nd edn., Cold Spring Harbor 
Laboratory Press, Cold Spring Harbor, NY. 
Provencher, S.W. and Gliickner, J. (1981) Biochemistry 20, 333 
37. 
194 C. Randak et al. IFEBS Letters 363 (1995) 189-194 
[17] Laemmli, U.K. (1970) Nature 227, 680-685. 
[18] Moczydlowski, E.G. and Fortes, P.A.G. (1981) J. Biol. Chem. 256, 
23462356. 
1191 Mullen, G.P., Shenbagamurthi, P. and Mildvan, A.S. (1989) _ _ 
J. Biol. Chem. 264, 19637-19647. 
I201 Nsrbv. J.G. (1988) Methods Enzvmol. 156. 116-l 19. 
[2lj Dennmg, GM., dstedgaard, L.S:, Cheng, S.H., Smith, A.E. and 
Welsh, M.J. (1992) J. Clin. Invest. 89, 339-349. 
[22] Schein, C.H. (1989) BiolTechnology 7, 1141-l 149. 
I231 Hemmingsen. S.M.. Woolford. C.. van der Vies. SM.. Tillv. K.. 
L , 
Dennis, D.T.: Georgopoulos, C.P.; Hendrix, R. W. and Ellis; R.J: 
(1988) Nature 333, 33&334. 
[24] Braig, K., Otwinowski, Z., Hegde, R., Boisvert, D.C., Joachimiak, 
A., Horwich, A.L. and Sigler, P.B. (1994) Nature 371, 578- 
586. 
[25] Martin, J., Langer, T., Boteva, R., Schramel, A., Horwich, A.L. 
and Hartl, F.-U. (1991) Nature 352, 3642. 
[26] Lakowicz, J.R. (1983) Principles of Fluorescence Spectroscopy, 
Plenum Press, New York. 
[27] Arispe, N., Rojas, E., Hartman, J., Sorscher, E.J. and Pollard, 
H.B. (1992) Proc. Natl. Acad. Sci. USA 89, 153991543. 
